{"type":"rich","version":"1.0","title":"MedPal AI on the Road to Breakeven","description":"Watch on YouTube\n (https://www.youtube.com/watch?v=N9YB9keYPXQ)\nMedPal AI Plc (AIM: MPAL) (https://www.voxmarkets.com/listings/MPAL:LN)   has snapped up the Remedi pharmacy assets out of administration for less than half a million pounds — a deal that brings with it an NHS dispensing hub in Runcorn, a care home patient book that historically delivered over £10 million in annualised turnover, and a fleet of BD Rowa robotic dispensing kit. Founder and CEO Jason Drummond joins us to unpack the numbers, explain how the Swaffham reactivation playbook will be re-run at scale across the new patient book, and lay out the path to pharmacy-level EBITDA breakeven at 80,000 items a month — pencilled in for October or November this year. We get into the strategic logic of a north-south footprint, where the execution risks sit, and how today’s deal fits into the bigger MedPal story across MedPal.clinic, Health OS and the at-home blood test business.","author_name":"The Vox Markets Podcast","author_url":"https://audioboom.com/channels/5051662-the-vox-markets-podcast","provider_name":"Audioboom","provider_url":"https://audioboom.com","width":480,"height":95,"thumbnail_url":"https://audioboom.com/i/40555564/600x600/c","thumbnail_width":600,"thumbnail_height":600,"html":""}